Saskatchewan Winters Last updated: Mon 04 Feb 2008 11:19 PM CST
Saskatchewan Blizzard
View Article  Rituxamab – Effective Against MS in Phase II Trial
Two doses of rituximab (Rituxan) diminished relapsing-remitting multiple sclerosis lesions and clinical symptoms for nearly a year, researchers   more »
View Article  Closer to Cure for Multiple Sclerosis and Other Myelin- related Diseases
A breakthrough finding on the mechanism of myelin formation could have a major impact on the treatment of diseases such as multiple sclerosis and demyelination as a result of    more »
View Article  Prevalence, Epidemiology, and Economic Burden
Since disease-modifying therapies (DMTs) have been available, considerable healthcare resources are used by MS patients. A healthcare utilization survey was carried out from   more »
View Article  Physical therapy is a mainstay
Physical therapy is a mainstay of patients of all types with physical disabilities. Studies of MS patients have shown variable results, probably due to many reasons, such as fatigue,   more »
View Article  Cognitive Dysfunction
Studies have shown that up to 65% of MS patients have cognitive dysfunction and that cognitive dysfunction is the greatest cause for disability. However, cognitive dysfunction is not well evaluated in the EDSS score nor   more »
View Article  Impact on Patients' Quality - Israel War
Studies examining the impact of stressful life events on MS exacerbations have given conflicting results. However, a study of war stress from the Carmel Medical Center in Haifa, Israel, after the Hezbollah-Israeli war in   more »